$58.66
+6.6%Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Last Annual Value
468.22M
3-Year CAGR
34%
5-Year CAGR
19%
10-Year CAGR
9%
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Hinge Health, Inc. NYSE:HNGE | 468.22M | 34.1% | N/A | N/A | |
![]() Lantheus Holdings, Inc. NASDAQ:LNTH | 941.95M | 9.9% | 38.1% | 21.2% | |
![]() Viking Therapeutics, Inc. NASDAQ:VKTX | -431.00K | N/A | N/A | N/A | |
![]() Akero Therapeutics, Inc. NASDAQ:AKRO | 0.00 | N/A | N/A | N/A | |
![]() Immunovant, Inc. NASDAQ:IMVT | 0.00 | N/A | N/A | N/A | |
![]() Dyne Therapeutics, Inc. NASDAQ:DYN | -2.05M | N/A | N/A | N/A | |
![]() Praxis Precision Medicines, Inc. NASDAQ:PRAX | -140.00K | N/A | N/A | N/A | |
![]() Indivior Pharmaceuticals Inc NASDAQ:INDV | 993.00M | 2.6% | 8.4% | 1.5% | |
![]() GeneDx Holdings Corp. NASDAQ:WGS | 298.17M | 49.1% | N/A | N/A | |
![]() Crinetics Pharmaceuticals, Inc. NASDAQ:CRNX | 2.73M | -12.1% | 20.4% | N/A | |
![]() Oscar Health, Inc. NYSE:OSCR | 1.68B | 11.3% | -2.6% | N/A |
Continue your HNGE research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.